Management of a caseous lymphadenitis outbreak in a new Iberian ibex (Capra pyrenaica) stock reservoir

Table 2 Lesions score: Number of clinical examinations performed in every handling divided by four lesion status: FL: Presence of fistulas; GLS: generalized lymph node swelling; LLS: Local lymph node swelling; NL: No apparent affectation; ND: No data

		Ibexes	FL	GLS	LLS	NL	ND
t0		18	0	0	0	18	0
t1		16	2	4	5	2	3
t2		14	2	2	6	3	1
t3		14	0	2	8	4	0
t4		14	0	0	2	12	0
t5		14	0	1	0	11	2
Period	Wild (t0)	18	0	0	0	18(100%)
Period	Captivity (t1-t5)	16	4(6.5%)	9(14%)	21(34%)	32(52%)
Treatment	Before (t1-t2)	16	4(18%)	6(27%)	11(50%)	5(23%)
Treatment	After (t3-t5)	14	0	3(7.5%)	10(25%)	27(67.5%)
CLA-ELISA	Negative	20	0	2(22.2%)	13(61.9%)	26(52%)
CLA-ELISA	Positive	20	4(100%)	7(77.8%)	8(38.1%)	24(48%)

These clinical examinations are put into groups to show the number of ibexes observed with every lesion status and the percentage they represent (in brackets) before (t0) and once in captivity (t1, t2, t3, t4, t5), before (t1 and t2) and after introducing treatment (t3, t4, t5) and in relation to the CLA-ELISA results. The number of ibexes present in every handling or included in every group is shown (Ibexes).

ISSN: 1751-0147